Nothing Special   »   [go: up one dir, main page]

BR0002577A - Suspensões orais de trovafloxacina - Google Patents

Suspensões orais de trovafloxacina

Info

Publication number
BR0002577A
BR0002577A BR0002577-1A BR0002577A BR0002577A BR 0002577 A BR0002577 A BR 0002577A BR 0002577 A BR0002577 A BR 0002577A BR 0002577 A BR0002577 A BR 0002577A
Authority
BR
Brazil
Prior art keywords
crystals
trovafloxacin
novel
suspensions
oral suspensions
Prior art date
Application number
BR0002577-1A
Other languages
English (en)
Inventor
Douglas John Meldrun Allen
Daniel Ray Arenson
Sojka Sonja Sekulic
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0002577A publication Critical patent/BR0002577A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção:<B>"SUSPENSõES ORAIS DE TROVAFLOXACINA"<D>. A invenção refere-se a suspensões para administração oral compreendendo novos cristais zwitteriónicos de trovafloxacina, e a processos para preparação dos referidos cristais. Esta invenção refere-se ainda a outras composições farmacêuticas compreendendo os referidos novos cristais, e aos métodos de utilização dessas suspensões, e dos novos cristais, em tais outras formas de dosagem, para tratar infecções bacterianas em mamíferos.
BR0002577-1A 1999-06-04 2000-06-05 Suspensões orais de trovafloxacina BR0002577A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13746399P 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
BR0002577A true BR0002577A (pt) 2001-01-02

Family

ID=22477550

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0002577-1A BR0002577A (pt) 1999-06-04 2000-06-05 Suspensões orais de trovafloxacina

Country Status (10)

Country Link
US (1) US6239141B1 (pt)
EP (1) EP1057828B1 (pt)
JP (1) JP3465820B2 (pt)
AT (1) ATE234835T1 (pt)
BR (1) BR0002577A (pt)
CA (1) CA2311112A1 (pt)
DE (1) DE60001687T2 (pt)
DK (1) DK1057828T3 (pt)
ES (1) ES2194677T3 (pt)
PT (1) PT1057828E (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226138B1 (en) * 1999-10-08 2004-12-29 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1372662A1 (en) * 2001-03-05 2004-01-02 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
EP1560584B1 (en) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
CA2453182A1 (en) * 2001-07-10 2003-01-23 Meredith L. Greene Crystalline thiazine oxazolidinones
PL216524B1 (pl) 2001-08-15 2014-04-30 Upjohn Co Kryształ obejmujący sól N-[2-(dietyloamino) etylo]-5-[(5-fluoro-1,2-dihydro-2-okso-3H-indolo-3-ylideno) metylo]-2,4-dimetylo-1H-pirolo-3-karboksyamidu z kwasem L-jabłkowym i zawierająca go kompozycja
CN100337630C (zh) * 2002-03-12 2007-09-19 布里斯托尔-迈尔斯斯奎布公司 可口的口服悬浮液及其制备方法
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
DK1575951T3 (da) 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
JP2006528182A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 薬学的製剤および酸に起因する消化器疾患の治療法
US8450307B2 (en) * 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
ME03392B (me) 2012-06-19 2020-01-20 Debiopharm Int Sa Prolek derivati (e)-n-meтil-n-( (з-метi lbenzofuran-2-il)meтil)-3-(7 -okso-5 ,6, 7,8-тетrанidr0-1,8-nafтiridin-3-il)akrilamida
CN108778286A (zh) 2016-02-26 2018-11-09 德彪药业国际股份公司 用于治疗糖尿病足感染的药物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5266559A (en) 1989-10-27 1993-11-30 Firmenich S.A. Use of unsaturated macrocyclic lactones as perfuming ingredients
US5391763A (en) 1990-07-11 1995-02-21 Pfizer Inc. 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids
TW271400B (pt) 1992-07-30 1996-03-01 Pfizer
JP3145715B2 (ja) 1995-06-06 2001-03-12 ファイザー・インコーポレーテッド 無水７−（［１α，５α，６α］−６−アミノ−３−アザビシクロ［３．１．０］ヘキサ−３−イル）−６−フルオロ−１−（２，４−ジフルオロフェニル）−１，４−ジヒドロ−４−オキソ−１，８−ナフチリディン−３−カルボン酸メタンスルホン酸塩の新規な結晶形態
TR199800339T1 (xx) * 1995-08-29 1998-06-22 Pfizer Inc. Trovafloksasinin melez iyonik bi�imleri.
RU2151152C1 (ru) * 1995-08-29 2000-06-20 Пфайзер Инк. Полиморфы 6-n-(l-ala-l-ala)-тровафлоксацина
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids

Also Published As

Publication number Publication date
DE60001687T2 (de) 2003-12-18
DE60001687D1 (de) 2003-04-24
PT1057828E (pt) 2003-07-31
ATE234835T1 (de) 2003-04-15
DK1057828T3 (da) 2003-07-14
EP1057828A3 (en) 2001-05-16
EP1057828B1 (en) 2003-03-19
EP1057828A2 (en) 2000-12-06
US6239141B1 (en) 2001-05-29
ES2194677T3 (es) 2003-12-01
CA2311112A1 (en) 2000-12-04
JP3465820B2 (ja) 2003-11-10
JP2000344770A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
BR0002577A (pt) Suspensões orais de trovafloxacina
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EA199901014A1 (ru) C-4&#34;-замещенные макролидные производные
TWI232219B (en) Compounds containing cyclohexane group, process for preparing them and pharmaceutical composition containing them
BG101118A (en) Therapeutical compounds
YU41500A (sh) Novi makrolidi
CY1111693T1 (el) Αντιιικοι παραγοντες
CA2292359A1 (en) Novel azalides and methods of making same
MY123354A (en) 4&#34;-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
MA25009A1 (fr) Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes
MXPA04012965A (es) Inhibidores virales.
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
NO996108L (no) 9-oksinerytromycinderivater
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
TR200102128T2 (tr) Ketolid antibiyotikler
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
AP2001002142A0 (en) 13-membered azalides and their use as antibiotic agents.
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
NO20042711L (no) Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
ITMI20021405A0 (it) Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell&#39;apparato respiratorio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.